$189.51
2.691.44%
al cierre: -
$189.51
0.000.00%
After hour: Oct 17, 4:00 PM EDT
Comments
Loading...
Quest Diagnostics Actividad de operaciones con información privilegiada
DGXNYSE
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Quest Diagnostics. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Quest Diagnostics.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Quest Diagnostics Inc los iniciados?
En Quest Diagnostics Inc, la reciente actividad interna ha llamado la atención. Durante los últimos 30 días, los insiders han informado que han vendido un total de - acciones por valor de -, mientras tanto, los insiders han no reportar compras en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
- El agosto 19, 2025, Patrick Plewman, la empresa SVP FOR DIAGNOSTIC SERVICES sold 1.98K acciones por $180 cada una.
- El agosto 25, 2025, Patrick Plewman, la empresa SVP FOR DIAGNOSTIC SERVICES sold 1.98K acciones por $185 cada una.
- El agosto 8, 2025, Patrick Plewman, la empresa SVP FOR DIAGNOSTIC SERVICES sold 1.98K acciones por $130.81 cada una.
Estadísticas de propiedad de Quest Diagnostics Inc
Acciones en circulación
111.823M
Acciones en manos de personas con información privilegiada
2.112M
Porcentaje de acciones en manos de personas con información privilegiada
1.89%
Acciones en manos de instituciones
85.601M
Porcentaje de acciones en manos de instituciones
76.6%
Sep 30, 2025 | SVP & GENERAL COUNSEL | 0.00 | $145.85 | -$19.20K | SELL-OPTIONS | 0.00% | 43.81K | Sep 26 | ||
Sep 25, 2025 | SVP & GENERAL COUNSEL | 0.00 | $145.35 | -$2.38M | SELL-OPTIONS | 0.00% | 43.81K | Sep 23 - Sep 24 | ||
Aug 25, 2025 | SVP FOR DIAGNOSTIC SERVICES | -1.98K | $185.00 | -$365.38K | SELL | -11.45% | 15.27K | Aug 21 | ||
Aug 21, 2025 | SVP FOR DIAGNOSTIC SERVICES | 0.00 | $147.59 | -$321.00K | SELL-OPTIONS | 0.00% | 17.24K | Aug 19 | ||
Aug 19, 2025 | SVP FOR DIAGNOSTIC SERVICES | -1.98K | $180.00 | -$355.50K | SELL | -10.28% | 17.24K | Aug 15 | ||
Aug 08, 2025 | SVP FOR DIAGNOSTIC SERVICES | -1.98K | $130.81 | -$660.22K | SELL | -9.32% | 19.22K | Aug 06 | ||
Aug 01, 2025 | SVP, CLINICAL SOLUTIONS | -2.21K | $135.36 | -$910.17K | SELL | -17.98% | 10.08K | Jul 30 - Jul 31 | ||
May 14, 2025 | SVP & CHIEF COMMERCIAL OFFICER | -1.75K | $175.51 | -$306.80K | SELL | -18.91% | 7.50K | May 12 - May 13 | ||
Apr 04, 2025 | CEO AND PRESIDENT | -39.19K | $168.46 | -$6.60M | SELL | -23.49% | 127.62K | Apr 02 | ||
Apr 04, 2025 | SVP, CLINICAL SOLUTIONS | -2.56K | $170.00 | -$434.35K | SELL | -17.33% | 12.19K | Apr 02 | ||
Mar 19, 2025 | SVP & GENERAL COUNSEL | -4.64K | $170.00 | -$789.31K | SELL | -9.59% | 43.76K | Mar 17 | ||
Mar 07, 2025 | EVP, REGIONAL BUSINESSES | -5.37K | $174.13 | -$935.08K | SELL | -6.90% | 72.50K | Mar 05 | ||
Mar 05, 2025 | EVP, REGIONAL BUSINESSES | 4.26K | $173.86 | $738.66K | GRANT | 5.79% | 77.86K | Mar 03 - Mar 04 | ||
Mar 05, 2025 | SVP & GENERAL COUNSEL | 3.73K | $173.87 | $646.66K | GRANT | 8.35% | 48.40K | Mar 03 - Mar 04 | ||
Feb 28, 2025 | SVP & GENERAL COUNSEL | -814.00 | $172.31 | -$140.26K | SELL | -1.79% | 44.67K | Feb 26 - Feb 27 | ||
Feb 28, 2025 | EVP, REGIONAL BUSINESSES | -1.28K | $172.30 | -$220.38K | SELL | -1.71% | 73.61K | Feb 26 - Feb 27 | ||
Feb 21, 2025 | SVP & GENERAL COUNSEL | -978.00 | $170.50 | -$166.75K | SELL | -2.10% | 45.49K | Feb 19 - Feb 20 | ||
Feb 21, 2025 | SVP FOR DIAGNOSTIC SERVICES | -320.00 | $169.71 | -$54.31K | SELL | -1.74% | 18.08K | Feb 19 | ||
Feb 21, 2025 | EVP, REGIONAL BUSINESSES | -1.43K | $170.51 | -$244.51K | SELL | -1.88% | 74.89K | Feb 19 - Feb 20 | ||
Feb 07, 2025 | DIRECTOR | -1.25K | $164.57 | -$205.71K | SELL | -6.90% | 16.87K | Feb 05 | ||
Feb 07, 2025 | SVP & CHIEF COMMERCIAL OFFICER | -403.00 | $164.30 | -$66.21K | SELL | -8.02% | 4.62K | Feb 05 | ||
Dec 02, 2024 | SVP & GENERAL COUNSEL | 0.00 | $124.85 | -$2.69M | SELL-OPTIONS | 0.00% | 44.10K | Nov 29 | ||
Dec 02, 2024 | EVP, REGIONAL BUSINESSES | 0.00 | $133.28 | -$1.97M | SELL-OPTIONS | 0.00% | 72.80K | Nov 27 | ||
Nov 07, 2024 | SVP, CORP. CONTROLLER & CAO | 0.00 | $111.35 | -$1.60M | SELL-OPTIONS | 0.00% | 35.63K | Nov 06 | ||
Oct 30, 2024 | SVP, CLINICAL SOLUTIONS | -1.77K | $156.92 | -$278.53K | SELL | -13.58% | 11.30K | Oct 28 | ||
Sep 03, 2024 | SVP & GENERAL COUNSEL | 0.00 | $125.38 | -$1.93M | SELL-OPTIONS | 0.00% | 44.07K | Aug 29 | ||
Aug 29, 2024 | SVP, CLINICAL SOLUTIONS | -1.99K | $153.26 | -$304.99K | SELL | -13.26% | 13.02K | Aug 28 | ||
Jul 26, 2024 | SVP & CHIEF COMMERCIAL OFFICER | -414.00 | $145.03 | -$59.21K | SELL | -7.62% | 5.02K | Jul 22 - Jul 24 | ||
May 01, 2024 | SVP, CLINICAL SOLUTIONS | -1.76K | $140.00 | -$246.40K | SELL | -10.51% | 14.99K | Apr 29 | ||
Mar 01, 2024 | EVP, REGIONAL BUSINESSES | -7.95K | $126.44 | -$1.00M | SELL | -9.84% | 72.76K | Feb 28 - Feb 29 | ||
Mar 01, 2024 | SVP & GENERAL COUNSEL | -6.47K | $125.94 | -$815.11K | SELL | -12.82% | 44.02K | Feb 28 - Feb 29 | ||
Feb 23, 2024 | SVP & GENERAL COUNSEL | -1.07K | $125.71 | -$134.26K | SELL | -2.28% | 45.75K | Feb 21 - Feb 22 | ||
Feb 23, 2024 | DIRECTOR | -2.50K | $126.64 | -$316.60K | SELL | -13.28% | 16.33K | Feb 23 | ||
Feb 23, 2024 | EVP, REGIONAL BUSINESSES | -1.31K | $125.72 | -$165.20K | SELL | -1.72% | 75.15K | Feb 21 - Feb 22 | ||
Mar 08, 2023 | SVP & GENERAL COUNSEL | 0.00 | $145.84 | $34.75K | GRANT | 0.00% | 43.94K | Mar 06 - Mar 07 | ||
Mar 08, 2023 | SVP, REGIONAL BUSINESSES | 0.00 | $145.90 | $38.79K | GRANT | 0.00% | 72.06K | Mar 06 - Mar 07 | ||
Mar 06, 2023 | SVP, REGIONAL BUSINESSES | -717.00 | $140.63 | -$100.83K | SELL | -0.99% | 72.06K | Mar 03 | ||
Mar 03, 2023 | SVP & GENERAL COUNSEL | -913.00 | $139.29 | -$127.18K | SELL | -2.04% | 43.94K | Mar 01 - Mar 02 | ||
Feb 27, 2023 | SVP & GENERAL COUNSEL | 216.00 | $143.77 | -$320.02K | GRANT | 0.48% | 44.85K | Feb 23 - Feb 24 | ||
Feb 27, 2023 | SVP, REGIONAL BUSINESSES | 1.19K | $143.76 | -$381.24K | GRANT | 1.65% | 73.17K | Feb 23 - Feb 24 | ||
Dec 05, 2022 | DIRECTOR | 0.00 | $104.94 | -$192.60K | SELL-OPTIONS | 0.00% | 24.15K | Dec 01 | ||
Nov 29, 2022 | SVP, REGIONAL BUSINESSES | 0.00 | $117.90 | -$2.55M | SELL-OPTIONS | 0.00% | 71.96K | Nov 28 | ||
Nov 02, 2022 | DIRECTOR | 0.00 | $102.56 | -$165.98K | SELL-OPTIONS | 0.00% | 24.15K | Nov 01 | ||
Oct 27, 2022 | VP, CORP. CONTROLLER & CAO | 0.00 | $99.40 | -$1.41M | SELL-OPTIONS | 0.00% | 32.67K | Oct 26 | ||
Oct 04, 2022 | DIRECTOR | 0.00 | $92.31 | -$124.33K | SELL-OPTIONS | 0.00% | 23.93K | Oct 03 | ||
Sep 06, 2022 | DIRECTOR | 0.00 | $93.12 | -$127.59K | SELL-OPTIONS | 0.00% | 23.93K | Sep 01 | ||
Aug 02, 2022 | DIRECTOR | 0.00 | $98.45 | -$150.37K | SELL-OPTIONS | 0.00% | 23.93K | Aug 01 | ||
Jul 05, 2022 | DIRECTOR | 0.00 | $95.46 | -$152.03K | SELL-OPTIONS | 0.00% | 23.93K | Jul 01 | ||
May 26, 2022 | CHAIRMAN, CEO AND PRESIDENT | 0.00 | $117.18 | -$1.18M | SELL-OPTIONS | 0.00% | 334.83K | May 25 | ||
May 25, 2022 | CHAIRMAN, CEO AND PRESIDENT | 0.00 | $117.17 | -$16.53M | SELL-OPTIONS | 0.00% | 334.83K | May 23 - May 24 | ||
May 19, 2022 | SVP & GENERAL COUNSEL | 0.00 | $103.24 | -$3.72M | SELL-OPTIONS | 0.00% | 44.56K | May 17 | ||
Mar 09, 2022 | SVP & GENERAL COUNSEL | 0.00 | $131.47 | -$31.89K | GRANT | 0.00% | 44.53K | Mar 07 - Mar 08 | ||
Mar 09, 2022 | SVP, GROUP EXEC. CLIN. FRAN. | 0.00 | $131.43 | -$36.00K | GRANT | 0.00% | 71.90K | Mar 07 - Mar 08 | ||
Mar 02, 2022 | SVP & GENERAL COUNSEL | -661.00 | $130.00 | -$85.93K | SELL | -1.46% | 44.53K | Feb 28 | ||
Feb 28, 2022 | SVP, GROUP EXEC. CLIN. FRAN. | 578.00 | $126.26 | -$347.21K | GRANT | 0.81% | 71.90K | Feb 24 | ||
Feb 28, 2022 | SVP & GENERAL COUNSEL | 1.07K | $126.26 | -$210.73K | GRANT | 2.43% | 45.19K | Feb 24 | ||
Dec 01, 2021 | SVP, GROUP EXEC. CLIN. FRAN. | 0.00 | $126.30 | -$2.29M | SELL-OPTIONS | 0.00% | 72.86K | Nov 29 | ||
Jul 30, 2021 | CHAIRMAN, CEO AND PRESIDENT | 0.00 | $117.99 | -$6.63M | SELL-OPTIONS | 0.00% | 284.43K | Jul 28 - Jul 29 | ||
Jul 28, 2021 | CHAIRMAN, CEO AND PRESIDENT | 0.00 | $117.90 | -$1.71M | SELL-OPTIONS | 0.00% | 284.43K | Jul 26 - Jul 27 | ||
Jul 28, 2021 | DIRECTOR | 0.00 | $99.35 | -$976.54K | SELL-OPTIONS | 0.00% | 31.22K | Jul 27 | ||
May 11, 2021 | SVP, GROUP EXEC. CLIN. FRAN. | -8.54K | $139.96 | -$1.19M | SELL | -10.49% | 72.83K | May 07 | ||
May 07, 2021 | SVP & GENERAL COUNSEL | 0.00 | $104.09 | -$2.96M | SELL-OPTIONS | 0.00% | 45.38K | May 05 | ||
Mar 11, 2021 | SVP & GENERAL COUNSEL | 0.00 | $116.86 | -$28.15K | GRANT | 0.00% | 45.36K | Mar 09 - Mar 10 | ||
Mar 01, 2021 | SVP & GENERAL COUNSEL | -801.00 | $115.49 | -$92.51K | SELL | -1.73% | 45.37K | Feb 25 | ||
Feb 25, 2021 | SVP & GENERAL COUNSEL | -2.34K | $119.02 | -$278.04K | SELL | -4.82% | 46.17K | Feb 23 - Feb 24 | ||
Dec 28, 2020 | — | 0.00 | $93.44 | -$4.40M | OPTION EXERCISE | 0.00% | 73.58K | Dec 24 | ||
Nov 27, 2020 | — | 0.00 | $91.84 | -$417.73K | OPTION EXERCISE | 0.00% | 29.86K | Nov 24 | ||
Nov 24, 2020 | — | -11.22K | $126.30 | -$1.42M | SELL | -28.36% | 28.35K | Nov 23 | ||
Oct 23, 2020 | — | 0.00 | $91.12 | -$708.01K | OPTION EXERCISE | 0.00% | 25.73K | Oct 21 | ||
Oct 19, 2020 | — | 0.00 | $93.25 | -$15.62M | OPTION EXERCISE | 0.00% | 237.75K | Oct 16 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.